Axsome Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options.
2024/11/4 19:24:15
(AXSM:NASDAQ)
Streetwise Reports Articles